ClinicalTrials.gg
RecruitingNCT07851740SIMPLE-PEEPUpdated Oct 9, 2026

BMI-Adjusted PEEP During One-Lung Ventilation in Thoracic Surgery

An interventional study of Fixed PEEP and BMI-adjusted PEEP in Pulmonary Resection Surgery, One Lung Ventillation (OLV) and General Anesthetic, sponsored by Jesús Manuel Nieves Alonso. Recruiting at 4 sites in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by Jesús Manuel Nieves Alonso · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Oct 2026; still recruiting 1 month later.
Updated Oct 9, 2026Now RecruitingSite recruiting status changed+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 31 studies in Hypoxia with a site in Spain — 11 open to participants now, 11 under way, 5 of them phase 3. Hypoxia · Spain.

Planned enrollment
4th of 25
150 · median 60
Started
2026
with 1 other
No phase
18 of 31
4 open now
Primary completion
2028-03
later than 9 of 10 live
Registered
31st of 31
by date

Among the 31 studies in Hypoxia with a site in Spain, this one is the 4th largest by planned enrollment of the 25 interventional ones that give a count, is one of 2 that started in 2026, is one of 18 with no phase, reaches primary completion later than 9 of the 10 other live ones, and was the 31st registered.

Hypoxia

1,081 studies on the registry are indexed under Hypoxia; 213 are open to participants now.

Browse Hypoxia studies →

Open to participants now

11 of the 31 studies in Hypoxia with a site in Spain are open now. Recruiting first, the newest first:

5 more — sign in →

All 11 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 124 Hypoxia studies recruiting now, 52 (42%) set no upper age limit and 46 (37%) stop at 75 or younger; 15 take children under 18; 35 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 31 studies in Hypoxia with a site in Spain, or all of them as a file.
02

Study summary

One-lung ventilation (OLV) is required during many thoracic surgical procedures and is associated with reduced functional residual capacity, atelectasis, ventilation-perfusion mismatch, hypoxemia, and potentially ventilator-induced lung injury. Lung-protective ventilation strategies include low tidal volumes, limitation of airway pressures, and positive end-expiratory pressure (PEEP), but the optimal PEEP level during OLV remains uncertain. Fixed PEEP is simple and reproducible but does not account for individual patient characteristics. Body mass index (BMI) is readily available before anesthesia and is associated with respiratory mechanics, making it a pragmatic candidate for simple PEEP individualization.

SIMPLE-PEEP is a prospective, multicenter, pragmatic, open-label, randomized clinical trial including 150 adults undergoing elective pulmonary resection under general anesthesia requiring OLV. Participants will be randomized to either fixed PEEP of 4 cmH2O or BMI-adjusted PEEP calculated as BMI/3 cmH2O. Other key components of lung-protective ventilation will be standardized between groups.

The primary outcome is driving pressure during the first 20 minutes of OLV, assessed at 5, 10, and 20 minutes after OLV initiation. Secondary outcomes include respiratory system compliance and other respiratory mechanics, estimated mechanical power, oxygenation, intraoperative hypoxemia and rescue maneuvers, hemodynamic safety, vasopressor requirements, and exploratory postoperative respiratory outcomes. No investigational medicinal product, additional invasive procedure, or study-specific advanced monitoring is required.

03

Conditions studied

  • Pulmonary Resection Surgery
  • One Lung Ventillation (OLV)
  • General Anesthetic

Browse trials for

Keywords

  • One-lung ventilation
  • Thoracic surgery
  • Lung resection
  • Positive end-expiratory pressure; PEEP
  • Body mass index; BMI
  • Respiratory mechanics
  • Driving pressure
  • Respiratory system compliance
  • Lung-protective ventilation
  • Hypoxemia
  • Postoperative pulmonary complications
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 18 years or older.
  2. Scheduled thoracic surgery for pulmonary resection requiring general anesthesia and one-lung ventilation.
  3. Written obtained before any study-specific procedure.

Exclusion criteria

Exclusion Criteria:

  1. Simultaneous participation in another interventional clinical trial that could interfere with the protocol.
  2. Severe hemodynamic instability before the start of the procedure, defined as continuous vasopressor infusion or shock of any etiology.
  3. Severe restrictive lung disease, defined as total lung capacity \<50% of predicted or forced vital capacity \<50% of predicted.
  4. >45 kg/m2.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • Active comparator
    Fixed PEEP of 4 cmH2O

    Procedure: Fixed PEEP

  • Experimental
    BMI-adjusted PEEP calculated as BMI/3 cmH2O

    Procedure: BMI-adjusted PEEP

Interventions

  • ProcedureFixed PEEP

    Fixed PEEP of 4 cmH2O

  • ProcedureBMI-adjusted PEEP

    BMI-adjusted PEEP calculated as BMI/3 cmH2O

06

What researchers measure

Primary outcomes

  1. Driving pressure during the primary T2-T4 window

    Driving pressure during the primary T2-T4 window, measured at 5, 10, and 20 minutes after initiation of one-lung ventilation and expressed in cmH2O. In conventional volume-controlled ventilation, driving pressure is calculated as plateau pressure minus applied PEEP. In pressure-regulated volume-targeted/volume-guaranteed modes, driving pressure is calculated as total end-inspiratory pressure minus applied PEEP.

    Time frame: 20 minutes

Secondary outcomes

  1. Respiratory system compliance

    Respiratory system compliance will be calculated at each applicable time point as tidal volume divided by driving pressure and expressed in mL/cmH2O

    Time frame: At 5, 10, and 20 minutes after initiation of one-lung ventilation; at 60 minutes when applicable; and at the end of one-lung ventilation, all during the surgical procedure on Day 1.

  2. Driving pressure at 60 minutes and at the end of one-lung ventilation

    Driving pressure will be assessed at 60 minutes after initiation of one-lung ventilation, when this time point is applicable, and at the actual end of one-lung ventilation, to evaluate the persistence of the physiological effect of the assigned PEEP strategy.

    Time frame: At 60 minutes after initiation of one-lung ventilation, when applicable, and at the end of one-lung ventilation.

  3. Estimated mechanical power during one-lung ventilation

    Ventilatory mechanical power will be estimated from prospectively recorded ventilatory parameters using a prespecified calculation method appropriate to the ventilation mode and expressed in J/min.

    Time frame: At 5, 10, and 20 minutes after initiation of one-lung ventilation; at 60 minutes when applicable; and at the end of one-lung ventilation, all during the surgical procedure on Day 1.

  4. Incidence of intraoperative hypoxemia during one-lung ventilation

    Intraoperative hypoxemia will be defined as SpO2 \<90% sustained for at least 60 seconds during one-lung ventilation with baseline FiO2 0.6, or any episode of SpO2 \<90% requiring immediate clinical intervention at the discretion of the attending anesthesiologist.

    Time frame: From initiation until completion of one-lung ventilation during the surgical procedure on Day 1 (up to 1 day).

  5. Incidence of major ventilatory rescue

    Major ventilatory rescue during the first 20 minutes after initiation of one-lung ventilation will be defined as any intervention that substantially modifies the assigned ventilatory strategy or respiratory mechanics, including modification of PEEP from the assigned value, recruitment maneuver, CPAP to the non-ventilated lung, temporary restoration of two-lung ventilation, or protocol interruption for safety reasons.

    Time frame: During the first 20 minutes after initiation of one-lung ventilation on Day 1.

  6. Incidence of intraoperative hypotension

    Intraoperative hypotension will be defined as mean arterial pressure \<65 mmHg sustained for more than 1 minute.

    Time frame: Intraoperative/periprocedural period on Day 1, from induction of anesthesia until the end of surgery.

  7. Requirement for intraoperative vasopressor support

    Proportion of participants requiring vasopressor administration during the intraoperative period. Vasopressor use will be recorded as a measure of the hemodynamic safety of the assigned PEEP strategy.

    Time frame: Time Frame: Intraoperative/periprocedural period on Day 1, from induction of anesthesia until the end of surgery.

  8. Incidence of postoperative pulmonary complications

    Occurrence of at least one prespecified postoperative pulmonary complication, including acute respiratory failure, pneumonia, acute respiratory distress syndrome, atelectasis, pneumothorax, bronchopleural fistula, aspiration pneumonitis, pulmonary embolism, pleural empyema, bronchospasm, pleural effusion, or need for postoperative respiratory support or reintubation for respiratory deterioration. This outcome will be considered exploratory.

    Time frame: From the end of surgery until hospital discharge during the index hospitalization (estimated average duration: 3-10 days).

07

Study locations

1 of 4 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Mar 2028, 16 months after the start.

Of 324 non-industry interventional studies with no phase under Hypoxia, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 27. This study's planned 16 months is above that.

Counting every sponsor, half of 354 studies reached it within 12 months; a quarter within 3 and three quarters within 27.

Start moved once since we started tracking on Sep 25, 2026: Nov 2026 → Oct 2026, on Oct 9, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 21, 2026
First posted
Oct 1, 2026
StartActual
Oct 7, 2026was Nov 2026
Primary completionEst.
Mar 1, 2028
CompletionEst.
Mar 30, 2028
Last update
Oct 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 9, 2026
Sites
4 sites changed recruiting status (3 now not yet recruiting, 1 now recruiting)
Show 4 sites
  • Hospital Clinic Barcelona · Barcelona, Spainno status→Not yet recruiting
  • Hospital de la Santa Creu i Sant Pau · Barcelona, Spainno status→Not yet recruiting
  • Hospital Universitario de La Princesa · Madrid, Spainno status→Recruiting
  • Hospital General Universitario Geogorio Marañón · Madrid, Spainno status→Not yet recruiting
Oct 9, 2026
Start date
Nov 1, 2026→Oct 7, 2026 (actual)
Oct 9, 2026
Registered
First appeared on the registry
Oct 1, 2026
Show all 2 updates
  1. Oct 9, 2026
    Not yet recruiting→Recruiting
    4 sites changed recruiting status (3 now not yet recruiting, 1 now recruiting)
    Show 4 sites
    • Hospital Clinic Barcelona · Barcelona, Spainno status→Not yet recruiting
    • Hospital de la Santa Creu i Sant Pau · Barcelona, Spainno status→Not yet recruiting
    • Hospital Universitario de La Princesa · Madrid, Spainno status→Recruiting
    • Hospital General Universitario Geogorio Marañón · Madrid, Spainno status→Not yet recruiting
    Start date Nov 1, 2026→Oct 7, 2026 (now actual)
    + 1 other change: verification date
  2. Oct 1, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07851740
Lead sponsor
Jesús Manuel Nieves Alonso
Responsible party
Jesús Manuel Nieves Alonso (Department of Anaesthesiology and Surgical Intensive Care, Fundación de Investigación Biomédica - Hospital Universitario de La Princesa) — Sponsor-investigator
First posted
Oct 1, 2026
Start date
Oct 7, 2026
Primary completion
Mar 1, 2028 (estimated)
Completion
Mar 30, 2028 (estimated)
Last update
Oct 9, 2026

Study contacts

Jesús M Nieves Alonso, MD
Contact
jesusmna@gmail.com
+34915202540

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion